Merrimack Pharmaceuticals Inc (MACK)

NASDAQ
4.350
-0.130(-2.90%)
After Hours
4.350
-0.012(-0.275%)
- Real-time Data
  • Volume:
    9,177
  • Bid/Ask:
    4.310/4.710
  • Day's Range:
    4.350 - 4.511

MACK Overview

Prev. Close
4.48
Day's Range
4.35-4.511
Revenue
-
Open
4.51
52 wk Range
3.56-9.45
EPS
-0.27
Volume
9,177
Market Cap
58.33M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
22,224
P/E Ratio
-
Beta
2.14
1-Year Change
16.06%
Shares Outstanding
13,410,243
Next Earnings Date
Nov 10, 2021
What is your sentiment on Merrimack Pharmaceuticals Inc?
or
Market is currently closed. Voting is open during market hours.

Merrimack Pharmaceuticals Inc News

Merrimack Pharmaceuticals Inc Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellStrong SellStrong Sell
Technical IndicatorsSellStrong SellStrong SellStrong SellStrong Sell
SummaryStrong SellStrong SellStrong SellStrong SellStrong Sell

Merrimack Pharmaceuticals Inc Company Profile

Merrimack Pharmaceuticals Inc Company Profile

Employees
0

Merrimack Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is entitled to receive contingent milestone payments related to its sale of ONIVYDE to Ipsen S.A. ONIVYDE is approved by the Unites States Food and Drug Administration (FDA) in combination with fluorouracil (5-FU) and leucovorin (LV) for the treatment of patients with metastatic adenocarcinoma of the pancreas after disease progression following gemcitabine-based therapy. The Company does not have any ongoing research or development activities and is seeking potential acquirers for its remaining preclinical and clinical assets.

Read More
  • Good time to buy
    0
    • strong buy
      0
      • time to buy
        0
        Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
        Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.